FDA approval for mint flavor nicotine gum

Download PDF Copy

Reviewed

Aug 3 2004

Watson Pharmaceuticals announced today that it has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application for nicotine polacrilex gum, mint flavor, in the 2 and 4 mg strengths.

Nicotine polacrilex gum, mint flavor, is the generic version of GlaxoSmithKline Consumer Healthcare's Nicorette(R) Mint gum, which is used as an aid to smoking cessation. The Company expects the product to be shipped by the end of the third quarter. For the 12-months ending June 2004, Nicorette(R) Mint gum had sales of approximately $75 million, according to IMS Health data.

Watson Pharmaceuticals, Inc., headquartered in Corona, CA, is a leading specialty pharmaceutical company that develops, manufactures, markets, sells and distributes brand and generic pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.

Source:

http://www.watsonpharm.com/

Posted in: Pharmaceutical News

Comments (0)

Download PDF Copy

Suggested Reading

Nicotine pouch use may be a step toward reducing more dangerous forms of tobacco

What are the benefits of chewing gum beyond oral health?

Study shows children inhale more microplastics inside school than outside

New guideline offers effective options to help Canadians quit smoking

Heated herbal product delivers nicotine with fewer toxins

Vaping linked to higher COPD risk, meta-analysis finds

Flavor bans linked to drop in e-cigarette use but may slow decline in smoking

Targeting brain pathway may ease nicotine withdrawal

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

(Logout)

Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.